ALPHA SOINS: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
ALPHA SOINS
Largest movements
- Receivables within one year +€7,264
up €7,264 (+4.0%), from €183,827 to €191,092
- Reserves +€8,037
up €8,037 (+5.6%), from €143,540 to €151,577
of which Distributable reserves: +€8,037
- Trade debts -€4,964
no longer reported in 2025 (was €4,964)
- Tax, wage and social debts +€4,193
up €4,193 (+45.9%), from €9,143 to €13,336
- Gross operating margin -€17,055
down €17,055 (-72.8%), from €23,414 to €6,359
- Taxes -€4,944
down €4,944 (-54.1%), from €9,137 to €4,193
- Financial income -€398
down €398 (-3.9%), from €10,198 to €9,800
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Cash or the result is not a separate line in both sets of accounts; the cash flow cannot be derived from them.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €184,399 | €191,092 | +€6,693 | +3.6% |
| Fixed assets | 21/28 | €552 | - | -€552 | |
| Tangible fixed assets | 22/27 | €552 | - | -€552 | |
| Furniture and vehicles | 24 | €552 | - | -€552 | |
| Current assets | 29/58 | €183,847 | €191,092 | +€7,245 | +3.9% |
| Amounts receivable within one year | 40/41 | €183,827 | €191,092 | +€7,264 | +4.0% |
| Other amounts receivable | 41 | €183,827 | €191,092 | +€7,264 | +4.0% |
| Deferred charges and accrued income | 490/1 | €19 | - | -€19 | |
| Total equity and liabilities | 10/49 | €184,399 | €191,092 | +€6,693 | +3.6% |
| Equity | 10/15 | €155,940 | €163,977 | +€8,037 | +5.2% |
| Contributions | 10/11 | €12,400 | €12,400 | = | 0.0% |
| Outside capital | 11 | €12,400 | €12,400 | = | 0.0% |
| Other | 1109/19 | €12,400 | €12,400 | = | 0.0% |
| Reserves | 13 | €143,540 | €151,577 | +€8,037 | +5.6% |
| Non-distributable reserves | 130/1 | €1,860 | €1,860 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,860 | €1,860 | = | 0.0% |
| Distributable reserves | 133 | €141,680 | €149,717 | +€8,037 | +5.7% |
| Amounts payable | 17/49 | €28,459 | €27,115 | -€1,344 | -4.7% |
| Amounts payable within one year | 42/48 | €28,459 | €27,115 | -€1,344 | -4.7% |
| Financial debts | 43 | €13,520 | €12,946 | -€574 | -4.2% |
| Credit institutions | 430/8 | €13,520 | €12,946 | -€574 | -4.2% |
| Trade debts | 44 | €4,964 | - | -€4,964 | |
| Suppliers | 440/4 | €4,964 | - | -€4,964 | |
| Taxes, remuneration and social security | 45 | €9,143 | €13,336 | +€4,193 | +45.9% |
| Taxes | 450/3 | €9,143 | €13,336 | +€4,193 | +45.9% |
| Other amounts payable | 47/48 | €833 | €833 | = | 0.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €732 | €552 | -€179 | -24.5% |
| Other operating charges | 640/8 | €387 | €400 | +€12 | +3.2% |
| Gross operating margin | 9900 | €23,414 | €6,359 | -€17,055 | -72.8% |
| Operating profit (loss) | 9901 | €22,295 | €5,407 | -€16,888 | -75.7% |
| Financial income | 75/76B | €10,198 | €9,800 | -€398 | -3.9% |
| Recurring financial income | 75 | €10,198 | €9,800 | -€398 | -3.9% |
| Financial charges | 65/66B | €2,361 | €2,143 | -€217 | -9.2% |
| Recurring financial charges | 65 | €2,361 | €2,143 | -€217 | -9.2% |
| Profit (loss) for the period before taxes | 9903 | €30,132 | €13,063 | -€17,069 | -56.6% |
| Income taxes | 67/77 | €9,137 | €4,193 | -€4,944 | -54.1% |
| Profit (loss) for the period | 9904 | €20,995 | €8,870 | -€12,125 | -57.8% |
| Profit (loss) for the period to be appropriated | 9905 | €20,995 | €8,870 | -€12,125 | -57.8% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 5 October 2026 via checked.be.